Vitaly Margulis, MD

Vitaly Margulis, MD, of UT Southwestern Medical Center

Articles by Vitaly Margulis, MD

The panelists share their insights on risk assessment, and customized treatment strategies for high-risk NMIBC.

The panelists discuss the evolving landscape of bladder cancer treatments, focusing on balancing bladder-sparing therapies.

The panelists debate the potential of combining intravesical immunotherapy with immune checkpoint inhibitors.

The panelists share their perspectives on SunRISe-1 and the evolving role of TAR-200 in treating BCG-unresponsive UC.

The second segment of this roundtable focuses on the evolving landscape of treatments for BCG-unresponsive bladder cancer.

Part one of this roundtable highlights current practices, emerging therapies, and the future landscape of NMIBC care.

Vitaly Margulis, MDUpper Tract Urothelial Carcinoma | June 10, 2024

Drs. Margulis and Murray showcase the ENLIGHTED study examining the efficacy and safety of padeliporfin VTP for LG UTUC.